Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Net Margin: 2016-2024

Historic Net Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -0.19%.

  • Organogenesis Holdings' Net Margin fell 108.00% to 9.63% in Q3 2025 from the same period last year, while for Sep 2025 it was -2.88%, marking a year-over-year decrease of 126.00%. This contributed to the annual value of -0.19% for FY2024, which is 134.00% down from last year.
  • Per Organogenesis Holdings' latest filing, its Net Margin stood at -0.19% for FY2024, which was down 117.03% from 1.14% recorded in FY2023.
  • Organogenesis Holdings' Net Margin's 5-year high stood at 20.31% during FY2021, with a 5-year trough of -0.19% in FY2024.
  • In the last 3 years, Organogenesis Holdings' Net Margin had a median value of 1.14% in 2023 and averaged 1.46%.
  • Its Net Margin has fluctuated over the past 5 years, first spiked by 2,014bps in 2020, then slumped by 1,686bps in 2022.
  • Over the past 5 years, Organogenesis Holdings' Net Margin (Yearly) stood at 5.09% in 2020, then soared by 1,521bps to 20.31% in 2021, then slumped by 1,686bps to 3.44% in 2022, then plummeted by 230bps to 1.14% in 2023, then tumbled by 134bps to -0.19% in 2024.